Insulet Corp - Company Profile

Powered by

All the data and insights you need on Insulet Corp in one report.

$395 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Insulet Corp Strategy Report

  • Understand Insulet Corp position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Insulet Corp: Overview

Select Item

Related keylists

Insulet Corp (Insulet) is a medical device company that develops, manufactures and distributes insulin management systems for diabetic patients. Its insulin management system, OmniPod, is a continuous insulin delivery system for insulin dependent diabetics. The OmniPod system consists of a disposable self- adhesive tubeless insulin infusion device, and a handheld wireless device, Personal Diabetes Manager. The company also works in partnership with various biotechnology and pharmaceutical companies that use the customized form of its OmniPod system to deliver drugs at specified intervals at predetermined doses. The company markets its products directly and through distributors in the US, Canada, Israel, China, and the UK, among others. Insulet is headquartered in Acton, Massachusetts, the US.

 Gain a 360-degree view of Insulet Corp and make more informed decisions for your business Gain a 360-degree view of Insulet Corp and make more informed decisions for your business Find out more
Headquarters United States of America
Address 100 Nagog Park, Acton, Massachusetts, 01720-3440
Website www.omnipod.com
Telephone 1 978 6007000
No of Employees 2,600
Industry Medical Equipment
Ticker Symbol & Exchange PODD (NASD)
Revenue (2022) $1.3B 18.8% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ -72.6% (2022 vs 2021)
Market Cap* $12.3B
Net Profit Margin (2022) XYZ -77.1% (2022 vs 2021)
* As of and is in US$
View Insulet Corp financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Insulet Corp premium industry data and analytics

40+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

6

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Insulet Corp’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
- -
OmniPod Insulin Management System Omnipod
OmniPod Insulin Delivery System Omnipod Dash
XYZ
XYZ
XYZ
Understand Insulet Corp portfolio and identify potential areas for collaboration Understand Insulet Corp portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Asset Purchase In February, the company acquired the assets of Automated Glucose Control LLC.
2023 Asset Purchase In February, the company acquired assets related to Bigfoot Biomedical’s pump-based automated insulin delivery (AID) technologies for US$25 million.
2022 Others In November, the company announced a Medical Device Correction for the Omnipod 5 Automated Insulin Delivery System.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Insulet Corp DexCom Inc West Pharmaceutical Services Inc Tandem Diabetes Care Inc Medtronic MiniMed Inc
Headquarters United States of America United States of America United States of America United States of America United States of America
City Acton San Diego Exton San Diego Los Angeles
State/Province Massachusetts California Pennsylvania California California
No. of Employees 2,600 7,500 10,700 2,600 -
Entity Type Public Public Public Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Jim Hollingshead President; Chief Executive Officer; Director Executive Board 2022 -
Bret Christensen Executive Vice President; Chief Commercial Officer Senior Management 2019 -
Dan Manea Chief Human Resources Officer; Senior Vice President Senior Management 2020 -
Trang Ly, Ph.D. Senior Vice President; Medical Director Senior Management 2018 -
Eric Benjamin Executive Vice President - Innovation, Strategy and Digital Products Senior Management 2022 -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Insulet Corp key executives to enhance your sales strategy Gain insight into Insulet Corp key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward